• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响氯化钾缓释片处方的因素。

Factors affecting the formulation of sustained release potassium chloride tablets.

作者信息

Senel S, Capan Y, Hincal A A

机构信息

Hacettepe University, Faculty of Pharmacy, Pharmaceutical Technology Department, Ankara, Turkey.

出版信息

Pharmazie. 1991 Nov;46(11):792-5.

PMID:1811230
Abstract

In this study, influence of several formulation factors on the release kinetics of potassium chloride from directly compressed matrices are investigated. Formulations containing hydrophilic (methylcellulose, carbomer), plastic (polyvinyl chloride), and wax (glycerol palmitostearate) matrix materials at concentrations of 10, 15 and 20%, incorporated with potassium chloride as active ingredient and insoluble excipients were prepared and studied in vitro using the USP XXI/NF XVI rotating paddle method. Hardness had no markedly effect on the release characteristics of formulations except for wax matrix material formulation. Results of goodness of fit analysis applied to release data had shown that the release mechanism was described by the Higuchi diffusion controlled model. Positive deviations from Higuchi equation might be due to the erosion of gel layer. Analysis of in vitro release mechanisms indicated that the most suitable results were obtained by methylcellulose and glycerol palmitostearate.

摘要

在本研究中,研究了几种制剂因素对直接压片基质中氯化钾释放动力学的影响。制备了含有浓度为10%、15%和20%的亲水性(甲基纤维素、卡波姆)、塑性(聚氯乙烯)和蜡质(甘油棕榈硬脂酸酯)基质材料的制剂,其中加入氯化钾作为活性成分和不溶性辅料,并采用美国药典 XXI/国家处方集 XVI 旋转桨法进行体外研究。除蜡质基质材料制剂外,硬度对制剂的释放特性没有明显影响。应用于释放数据的拟合优度分析结果表明,释放机制符合 Higuchi 扩散控制模型。与 Higuchi 方程的正偏差可能是由于凝胶层的侵蚀。体外释放机制分析表明,甲基纤维素和甘油棕榈硬脂酸酯获得了最合适的结果。

相似文献

1
Factors affecting the formulation of sustained release potassium chloride tablets.影响氯化钾缓释片处方的因素。
Pharmazie. 1991 Nov;46(11):792-5.
2
Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.用于控释药物的羟丙基甲基纤维素亲水基质的临界点研究。
Int J Pharm. 2006 Mar 27;311(1-2):75-81. doi: 10.1016/j.ijpharm.2005.12.012. Epub 2006 Jan 30.
3
Formulation study and drug release mechanism of a new theophylline sustained-release preparation.一种新型茶碱缓释制剂的处方研究及释药机制
Int J Pharm. 2005 Nov 4;304(1-2):91-101. doi: 10.1016/j.ijpharm.2005.07.022. Epub 2005 Sep 8.
4
Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.混合物实验设计在含卡波姆和羟丙甲纤维素的基质片剂的配方和优化中的应用。
Arch Pharm Res. 2009 Dec;32(12):1767-74. doi: 10.1007/s12272-009-2215-9. Epub 2010 Feb 17.
5
Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.使用羟丙基甲基纤维素评估布洛芬骨架片的药物释放动力学。
Pak J Pharm Sci. 2006 Apr;19(2):119-24.
6
Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.塑料、疏水性和亲水性聚合物作为控释药物递送基质的比较评价。
J Pharm Pharm Sci. 2003 May-Aug;6(2):282-91.
7
Effect of polysorbates on drug release from wax matrices.
Drug Dev Ind Pharm. 1998 Jun;24(6):573-6. doi: 10.3109/03639049809085661.
8
Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.从ATO 888基质中持续释放盐酸苯丙醇胺。
P R Health Sci J. 1993 Dec;12(4):263-7.
9
Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.基于亲水性聚合物的载茶碱胃滞留漂浮片:制备与体外评价
Pak J Pharm Sci. 2009 Apr;22(2):155-61.
10
Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.盐酸二甲双胍胃内滞留漂浮片的设计与体外测试
Pharmazie. 2007 Feb;62(2):145-8.

引用本文的文献

1
Mucoadhesive bilayered buccal platform for antifungal drug delivery into the oral cavity.用于将抗真菌药物递送入口腔的粘膜粘附双层颊片平台。
Drug Deliv Transl Res. 2021 Feb;11(1):318-327. doi: 10.1007/s13346-020-00798-1.
2
Controlled release drugs in overdose. Clinical considerations.过量服用的控释药物。临床考量。
Drug Saf. 1995 Jan;12(1):73-84. doi: 10.2165/00002018-199512010-00006.